Chlorpromazine inhibits mitochondrial apoptotic pathway via increasing expression of tissue factor
Chlorpromazine inhibits mitochondrial apoptotic pathway via increasing expression of tissue factor
复制标题
氯丙嗪通过增加组织因子表达抑制线粒体凋亡途径
DOI:
10.1016/j.biocel.2015.11.008
复制
发表时间:
2016
影响因子:
4
通讯作者:
Zhang Fengmin
中科院分区:
文献类型:
--
作者:
Wu Jing;Li Aimei;Li Yujun;Li Xiaoguang;Zhang Qingmeng;Song Wuqi;Wang Yao;Ogutu James O.;Wang Jindong;Li Jianbo;Tang Renkuan;Zhang Fengmin
Chlorpromazine (CPZ) is a widely used antipsychotic drug with antagonistic effect on dopamine receptors. Accumulating evidence has shown that CPZ plays a neuroprotective role in various models of toxicity and apoptosis. However, the underlying mechanism contributing to this protective effect remains unclear. Here, we evaluate the effect of CPZ on mitochondrial apoptotic pathway in the neuron system. Higher levels of B-cell lymphoma-2 (Bcl-2) and tissue factor (TF) but lower apoptotic rate were found in hippocampus of CPZ-treated schizophrenic patients compared with non-antipsychotic treated controls. Additionally, both short-term and long-term treatment of CPZ in rats could up-regulate the levels of Bcl-2 and TF with no cytotoxic effects. In the in vitro experiment, expression of Bcl-2 was up-regulated in the C6 glioma cells transfected with pEGFP-N1-TF recombinant plasmid. Furthermore, in another independent rat model of apoptosis, compared with the group administrated with alcohol only, the brains of the CPZ-pretreated rats showed lower expression of cleaved caspase-3, cytochrome c and Bax, but higher expression of Bcl-2 and TF. Our data demonstrate that CPZ exerts its neuronal protective effects through inhibiting the activation of mitochondrial apoptotic pathway by up-regulating TF expression, thus providing new insight into CPZ function and application.